{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:55:30Z","timestamp":1784836530576,"version":"3.55.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>For the past 70 years, controversy about hypoglycemia in newborn infants has focused on a numerical \u201cdefinition of neonatal hypoglycemia\u201d, without regard to its mechanism. This ignores the purpose of screening newborns for hypoglycemia, which is to identify those with pathological forms of hypoglycemia and to prevent hypoglycemic brain injury. Recent clinical and basic research indicates that the three major forms of neonatal hypoglycemia are caused by hyperinsulinism (recognizing also that other rare hormonal or metabolic conditions may also present during this time frame). These include transitional hypoglycemia, which affects all normal newborns in the first few days after birth; perinatal stress-induced hypoglycemia in high-risk newborns, which afflicts \u223c1 in 1,200 newborns; and genetic forms of congenital hyperinsulinism which afflict \u223c1 in 10,000\u201340,000 newborns. (1) Transitional hyperinsulinism in normal newborns reflects persistence of the low glucose threshold for insulin secretion during fetal life into the first few postnatal days. Recent data indicate that the underlying mechanism is decreased trafficking of ATP-sensitive potassium channels to the beta-cell plasma membrane, likely a result of the hypoxemic state of fetal life. (2) Perinatal stress-induced hyperinsulinism in high-risk infants appears to reflect an exaggeration of this normal low fetal glucose threshold for insulin release due to more severe and prolonged exposure to perinatal hypoxemia. (3) Genetic hyperinsulinism, in contrast, reflects permanent genetic defects in various steps controlling beta-cell insulin release, such as inactivating mutations of the <jats:italic>K<\/jats:italic><jats:sub>ATP<\/jats:sub>-channel genes. The purpose of this report is to review our current knowledge of these three major forms of neonatal hyperinsulinism as a foundation for the diagnosis and management of hypoglycemia in newborn infants. This includes selection of appropriate interventions based on underlying disease mechanism; combined monitoring of both plasma glucose and ketone levels to improve screening for infants with persistent forms of hypoglycemia; and ultimately to ensure that infants at risk of persistent hyperinsulinemic hypoglycemia are recognized prior to discharge from the nursery.<\/jats:p>","DOI":"10.3389\/fped.2023.1071206","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T05:45:57Z","timestamp":1678427157000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["New approaches to screening and management of neonatal hypoglycemia based on improved understanding of the molecular mechanism of hypoglycemia"],"prefix":"10.3389","volume":"11","author":[{"given":"Charles A.","family":"Stanley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diva D.","family":"De Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2337\/diab.26.11.1016","article-title":"Measurement of \u201ctrue\u201d glucose production rates in infancy and childhood with 6,6-dideuteroglucose","volume":"26","author":"Bier","year":"1977","journal-title":"Diabetes"},{"key":"B2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jpeds.2015.03.057","article-title":"Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children","volume":"167","author":"Thornton","year":"2015","journal-title":"J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jpeds.2020.12.063","article-title":"Alternative cerebral fuels in the first five days in healthy term infants: the glucose in well babies (GLOW) study","volume":"231","author":"Harris","year":"2021","journal-title":"J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1542\/peds.105.5.1141","article-title":"Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds","volume":"105","author":"Cornblath","year":"2000","journal-title":"Pediatrics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1504909","article-title":"Neonatal glycemia and neurodevelopmental outcomes at 2 years","volume":"373","author":"McKinlay","year":"2015","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jamapediatrics.2017.1579","article-title":"Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years","volume":"171","author":"McKinlay","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jama.2022.0992","article-title":"Association of neonatal hypoglycemia with academic performance in mid-childhood","volume":"327","author":"Shah","year":"2022","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1056\/NEJMoa1905593","article-title":"Lower versus traditional treatment threshold for neonatal hypoglycemia","volume":"382","author":"van Kempen","year":"2020","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1542\/peds.107.3.476","article-title":"Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia","volume":"107","author":"Menni","year":"2001","journal-title":"Pediatrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pedn.2004.12.009","article-title":"Effects of hypoglycemia on developmental outcome in children with congenital hyperinsulinism","volume":"20","author":"Steinkrauss","year":"2005","journal-title":"J Pediatr Nurs"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2015-2539","article-title":"High risk of diabetes and neurobehavioral deficits in individuals with surgically treated hyperinsulinism","volume":"100","author":"Lord","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.jpeds.2015.02.045","article-title":"Re-evaluating \u201ctransitional neonatal hypoglycemia\u201d: mechanism and implications for management","volume":"166","author":"Stanley","year":"2015","journal-title":"J Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJM196508122730707","article-title":"Blood glucose in the neonate and its clinical significance","volume":"273","author":"Cornblath","year":"1965","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1542\/peds.47.5.831","article-title":"Incidence of hypoglycemia in newborn infants classified by birth weight and gestational age","volume":"47","author":"Lubchenco","year":"1971","journal-title":"Pediatrics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.09.447705","article-title":"Early postnatal activation of the hypoxia pathway disrupts \u00df-cell function","author":"Yang","year":"2021","journal-title":"bioRxiv"},{"key":"B17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jpeds.2012.05.022","article-title":"Incidence of neonatal hypoglycemia in babies identified as at risk","volume":"161","author":"Harris","year":"2012","journal-title":"J Pediatr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.999274","article-title":"Natural history and neurodevelopmental outcomes in perinatal stress induced hyperinsulinism","author":"Sigal","year":"2022","journal-title":"Front Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(65)92025-8","article-title":"The smaller of twins and hypoglycaemia","volume":"1","author":"Reisner","year":"1965","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1056\/NEJM196806062782304","article-title":"Hypoglycemia and hyperinsulinism in infants with erythroblastosis fetalis","volume":"278","author":"Barrett","year":"1968","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(84)92685-0","article-title":"Hyperinsulinism in asphyxiated and small-for-dates infants with hypoglycaemia","volume":"2","author":"Collins","year":"1984","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jpeds.2005.10.002","article-title":"Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism","volume":"148","author":"Hoe","year":"2006","journal-title":"J Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1542","DOI":"10.1210\/clinem\/dgab024","article-title":"Long-term outcome and treatment in persistent and transient congenital hyperinsulinism: a Finnish population-based study","volume":"106","author":"Mannisto","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0228417","DOI":"10.1371\/journal.pone.0228417","article-title":"Using referral rates for genetic testing to determine the incidence of a rare disease: the minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389","volume":"15","author":"Yau","year":"2020","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E1540","DOI":"10.1210\/jc.2015-2763","article-title":"High incidence of heterozygous ABCC8 and HNF1A mutations in Czech patients with congenital hyperinsulinism","volume":"100","author":"Rozenkova","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","first-page":"563","article-title":"Clinical characteristics of congenital hyperinsulinemic hypoglycemia in infant: a nationwide epidemiological survey in Japan","volume":"115","author":"Kawakita","year":"2011","journal-title":"Nihon Shonika Gakkai Zasshi"},{"key":"B27","doi-asserted-by":"publisher","first-page":"E355","DOI":"10.1210\/jc.2012-2169","article-title":"Genotype and phenotype correlations in 417 children with congenital hyperinsulinism","volume":"98","author":"Snider","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fphys.2019.00148","article-title":"The central role of glucokinase in glucose homeostasis: a perspective 50 years after demonstrating the presence of the enzyme in islets of langerhans","volume":"10","author":"Matschinsky","year":"2019","journal-title":"Front Physiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1056\/NEJM199805073381904","article-title":"Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene","volume":"338","author":"Stanley","year":"1998","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/pedi.12655","article-title":"Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations","volume":"19","author":"Tung","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1464-5491.2000.00247.x","article-title":"Ions, genes and insulin release: from basic science to clinical disease. Based on the 1998 R. D. Lawrence lecture","volume":"17","author":"Dunne","year":"2000","journal-title":"Diabet Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nbt.2141","article-title":"Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3","volume":"30","author":"Blum","year":"2012","journal-title":"Nat Biotechnol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1073\/pnas.1400709111","article-title":"Differentiated human stem cells resemble fetal, not adult, beta cells","volume":"111","author":"Hrvatin","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2337\/db17-1433","article-title":"Regulation of KATP channel trafficking in pancreatic beta-cells by protein histidine phosphorylation","volume":"67","author":"Srivastava","year":"2018","journal-title":"Diabetes"},{"key":"B35","first-page":"14","article-title":"The distinction between \u201cglucose setpoint\u201d, \u201cglucose threshold\u201d and \u201cglucose sensor\u201d is critical for undestanding the role of the pancreatic B-cell in glucose homeostasis","author":"Matschinsky","year":"1998"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab121","article-title":"Decreased KATP channel activity contributes to the low glucose threshold for insulin secretion of rat neonatal islets","volume":"162","author":"Yang","year":"2021","journal-title":"Endocrinology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clp.2021.11.007","article-title":"Advances in understanding the mechanism of transitional neonatal hypoglycemia and implications for management","volume":"49","author":"Stanescu","year":"2022","journal-title":"Clin Perinatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1907362","article-title":"Effects of germline VHL deficiency on growth, metabolism, and mitochondria","volume":"382","author":"Perrotta","year":"2020","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1172\/JCI121994","article-title":"Human islets expressing HNF1A variant have defective beta cell transcriptional regulatory networks","volume":"129","author":"Haliyur","year":"2019","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1172\/JCI200522365","article-title":"The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion","volume":"115","author":"Gupta","year":"2005","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1056\/NEJMra002168","article-title":"Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young","volume":"345","author":"Fajans","year":"2001","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"322","DOI":"10.2337\/diabetes.50.2.322","article-title":"Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations","volume":"50","author":"Grimberg","year":"2001","journal-title":"Diabetes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fendo.2013.00060","article-title":"Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism","volume":"4","author":"Avatapalle","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11892-019-1216-4","article-title":"Novel preparations of glucagon for the prevention and treatment of hypoglycemia","volume":"19","author":"Hawkes","year":"2019","journal-title":"Curr Diab Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000497458","article-title":"Rate of serious adverse events associated with diazoxide treatment of patients with hyperinsulinism","volume":"91","author":"Thornton","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1210\/jc.2018-01613","article-title":"Prevalence of adverse events in children with congenital hyperinsulinism treated with diazoxide","volume":"103","author":"Herrera","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa543","article-title":"Management and appropriate use of diazoxide in infants and children with hyperinsulinism","volume":"105","author":"Brar","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1071206\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T05:46:00Z","timestamp":1678427160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1071206\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":47,"alternative-id":["10.3389\/fped.2023.1071206"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1071206","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"article-number":"1071206"}}